Literature DB >> 27935072

Physical exercise in myasthenia gravis is safe and improves neuromuscular parameters and physical performance-based measures: A pilot study.

Elisabet Westerberg1,2, Carl Johan Molin1, Ida Lindblad1, Margareta Emtner3,4, Anna Rostedt Punga1.   

Abstract

INTRODUCTION: Due to the shortage of exercise-related research in Myasthenia Gravis (MG), there are no consensus guidelines on physical exercise for MG patients.
METHODS: In this prospective pilot study, 10 MG patients with mild disease performed supervised aerobic and resistance training twice weekly for 12 weeks. The Myasthenia Gravis Composite (MGC) score, compound motor action potential (CMAP), repetitive nerve stimulation, muscle force, physical performance-based measures, serum levels of interleukin-6, muscle enzymes, and immuno-microRNAs miR-150-5p and miR-21-5p were assessed before and after the training period.
RESULTS: Physical exercise was well tolerated, and the MGC score was unchanged. Muscle resistance weights and CMAP amplitudes increased for biceps brachii and rectus femoris muscles, and physical performance-based measures improved. Muscle enzymes remained normal, whereas disease-specific microRNAs miR-150-5p and miR-21-5p were reduced after the training period.
CONCLUSIONS: We propose that general recommendations regarding physical exercise can be applied safely to well-regulated MG patients. Muscle Nerve 56: 207-214, 2017.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  CMAP; microRNA; myasthenia gravis; neuromuscular; physical exercise; resistance training

Mesh:

Substances:

Year:  2017        PMID: 27935072     DOI: 10.1002/mus.25493

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  14 in total

1.  Social, professional and neuropsychiatric outcomes in patients with myasthenia gravis.

Authors:  Bruno Kusznir Vitturi; Alexandre In Han Kim; Lucas Pari Mitre; Ada Pellegrinelli; Berenice Cataldo Oliveira Valerio
Journal:  Neurol Sci       Date:  2020-06-26       Impact factor: 3.307

Review 2.  Regulation of microRNAs in Alzheimer´s disease, type 2 diabetes, and aerobic exercise training.

Authors:  Ricardo Augusto Leoni De Sousa; Alex Cleber Improta-Caria
Journal:  Metab Brain Dis       Date:  2022-01-25       Impact factor: 3.584

3.  Serum irisin levels in patients with myasthenia gravis.

Authors:  Sheng-Nan Zhang; Qi Li; Qiu-Xia Zhang; Tian-Xiao Gao; Sheng-Hui Chang; Da-Qi Zhang; Lin-Jie Zhang; Li Yang
Journal:  Neurol Sci       Date:  2021-10-28       Impact factor: 3.830

Review 4.  A Practical Approach to Managing Patients With Myasthenia Gravis-Opinions and a Review of the Literature.

Authors:  Maria Elena Farrugia; John A Goodfellow
Journal:  Front Neurol       Date:  2020-07-07       Impact factor: 4.003

Review 5.  Application Prospect of Artificial Intelligence in Rehabilitation and Management of Myasthenia Gravis.

Authors:  Ying Zhang; Hongmei Yu; Rui Dong; Xuan Ji; Fujun Li
Journal:  Biomed Res Int       Date:  2021-03-04       Impact factor: 3.411

6.  The benefits and tolerance of exercise in myasthenia gravis (MGEX): study protocol for a randomised controlled trial.

Authors:  Simone Birnbaum; Jean-Yves Hogrel; Raphael Porcher; Pierre Portero; Bernard Clair; Bruno Eymard; Sophie Demeret; Guillaume Bassez; Marcela Gargiulo; Estelle Louët; Sonia Berrih-Aknin; Asmaa Jobic; Philippe Aegerter; Philippe Thoumie; Tarek Sharshar
Journal:  Trials       Date:  2018-01-18       Impact factor: 2.279

7.  Thymectomy lowers the myasthenia gravis biomarker miR-150-5p.

Authors:  Carl Johan Molin; Liis Sabre; Cleo-Aron Weis; Tanel Punga; Anna Rostedt Punga
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2018-03-01

8.  The impact of physical exercise on neuromuscular function in Myasthenia gravis patients: A single-subject design study.

Authors:  Elisabet Westerberg; Carl Johan Molin; Sören Spörndly Nees; Johan Widenfalk; Anna Rostedt Punga
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

9.  Marathons and myasthenia gravis: a case report.

Authors:  Simone Birnbaum; Tarek Sharshar; Bruno Eymard; Marie Theaudin; Pierre Portero; Jean-Yves Hogrel
Journal:  BMC Neurol       Date:  2018-09-18       Impact factor: 2.474

Review 10.  Circulating miRNAs as Potential Biomarkers in Myasthenia Gravis: Tools for Personalized Medicine.

Authors:  Liis Sabre; Tanel Punga; Anna Rostedt Punga
Journal:  Front Immunol       Date:  2020-03-04       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.